TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21411836

Group type: EXPERIMENTAL
Intervention: Probiotic (Lactobacillus casei Shirota)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 19420956

Group type: EXPERIMENTAL
Intervention: Arsenicum album
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Natrum muriaticum
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 17014273

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral group intervention for coping with AIDS bereavement (12-week duration)
Number of subjects: 267

Group type: COMPARATOR
Intervention: Individual therapy upon request
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral group intervention for coping with AIDS bereavement
Number of subjects: 267
Study: 15244255

Group type: EXPERIMENTAL
Intervention: CHOP chemotherapy
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: CNOP chemotherapy
Number of subjects: 220
Study: 11052327

Group type: EXPERIMENTAL
Intervention: Late scan (3 hr)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Early scan (45 min)
Number of subjects: 80
Study: 9387196

Group type: EXPERIMENTAL
Intervention: Ozone exposure (0.22 ppm for 4 hours with exercise)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Air exposure (same exposure protocol)
Number of subjects: 90
Study: 7935030

Group type: EXPERIMENTAL
Intervention: Conjugated estrogens, 0.625 mg daily
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Conjugated estrogens with cyclic medrogestone, 5 mg daily during the last 12 days of each 28 days treatment cycle
Number of subjects: 33
Study: 3154698

Group type: EXPERIMENTAL
Intervention: Molsidomine (4 mg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Nifedipine (20 mg)
Number of subjects: 32
Study: 30090923

Group type: EXPERIMENTAL
Intervention: Heavier sedation (modified observer's assessment of sedation score of 0-2)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Lighter sedation (observer's assessment of sedation score of 3-5)
Number of subjects: 200
Study: 28406752

Group type: EXPERIMENTAL
Intervention: PCECV-I (Indian batches)
Number of subjects: 340

Group type: COMPARATOR
Intervention: PCECV-G (German batch)
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: PCECV-I and PCECV-G (all groups)
Number of subjects: 340
Study: 25684609

Group type: EXPERIMENTAL
Intervention: Winking emoticon present
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: No emoticon present
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gender
Number of subjects: 0
Study: 23254230

Group type: EXPERIMENTAL
Intervention: Bupropion 150mg bid for 7 weeks
Number of subjects: 540

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 540

Group type: COMPARATOR
Intervention: Bupropion vs. Placebo
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Greater study session attendance
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Longer years of smoking
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Higher baseline cotinine
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: BMI
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Weight efficacy
Number of subjects: 540
Study: 20667666

Group type: EXPERIMENTAL
Intervention: Acute cocaine use
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Acute heavy alcohol use
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Male gender
Number of subjects: 160
Study: 18256071

Group type: EXPERIMENTAL
Intervention: Ipratropium 80 mug followed by Salbutamol 400 mug
Number of subjects: 5756

Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 5756
Study: 16724575

Group type: EXPERIMENTAL
Intervention: Fixed bacterium combination of Lactobacillus gasseri and Bifidobacterium longum
Number of subjects: 169

Group type: COMPARATOR
Intervention: Mono-bacterium Enterococcus faecium
Number of subjects: 169
Study: 12195132

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 9193

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 9193
Study: 9706939

Group type: EXPERIMENTAL
Intervention: ETT cuff inflation in the pharynx
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fiberoptic bronchoscopy
Number of subjects: 20
Study: 7891047

Group type: EXPERIMENTAL
Intervention: Tablets containing 66 mg ferrous iron (as fumarate) daily
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 2204651

Group type: EXPERIMENTAL
Intervention: Golytely
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Enema preparation
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 124
Study: 656287

Group type: EXPERIMENTAL
Intervention: Large particle size digoxin
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Metoclopramide
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Propantheline
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Standard digoxin
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 7083601

Group type: EXPERIMENTAL
Intervention: Testosterone undecanoate (TU) 160 mg daily by mouth
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study: 31200994

Group type: EXPERIMENTAL
Intervention: Moving incision
Number of subjects: 516

Group type: COMPARATOR
Intervention: Conventional incision
Number of subjects: 516
Study: 29565951

Group type: EXPERIMENTAL
Intervention: 30 mL of 0.25% bupivacaine plus 1 µg/kg dexmedetomidine (GD group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 30 mL of 0.25% bupivacaine only (GB group)
Number of subjects: 60
Study: 27436880

Group type: EXPERIMENTAL
Intervention: Pravastatin treatment arm
Number of subjects: 4428

Group type: COMPARATOR
Intervention: Placebo treatment arm
Number of subjects: 4428
Study: 24798770

Group type: EXPERIMENTAL
Intervention: dolutegravir/abacavir/lamivudine FDC tablet
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: dolutegravir/abacavir/lamivudine FDC tablet with a high-fat meal
Number of subjects: 66
Study: 22776095

Group type: EXPERIMENTAL
Intervention: Moderate- to high-intensity Nordic Walking (NW) program (n = 26)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Supervised low-intensity walking (LIW) program (n = 23)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Both NW and LIW groups
Number of subjects: 49
Study: 20852413

Group type: EXPERIMENTAL
Intervention: Moderate intensity cyclette exercise (≤70% maximum heart rate)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Seated rest (control condition)
Number of subjects: 10
Study: 17687882

Group type: EXPERIMENTAL
Intervention: CRA Plus Vouchers
Number of subjects: 37

Group type: COMPARATOR
Intervention: Standard Treatment
Number of subjects: 37
Study: 15843697

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) via face mask with patient controlled analgesia (PCA)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Intermittent Positive Pressure Ventilation (IPPV) with endotracheal intubation (ETI)
Number of subjects: 52
Study: 11887531

Group type: EXPERIMENTAL
Intervention: Atraumatic restorative treatment (ART) for Class I cavity preparations
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Atraumatic restorative treatment (ART) for Class II cavity preparations
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional cavity preparation for Class II cavity preparations
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional cavity preparation for Class I cavity preparations
Number of subjects: 60

Group type: COMPARATOR
Intervention: Amalgam restorations in Class I conventional preparations
Number of subjects: 60
Study: 9790334

Group type: EXPERIMENTAL
Intervention: rhGH (0.2 mg/kg/day subcutaneously)
Number of subjects: 263

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: rhGH (therapeutically)
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: rhGH
Number of subjects: 263
Study: 7631514

Group type: EXPERIMENTAL
Intervention: High-dose Edmonston-Zagreb strain (10(5.6) TDIC50)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Low-dose Connaught strain (10(3) TCID50)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Medium-dose Schwarz strain (10(4) TCID50)
Number of subjects: 85
Study: 2560000

Group type: EXPERIMENTAL
Intervention: Small group education for general practitioners (8 meetings discussing chronic asthma management)
Number of subjects: 454

Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 454
Study: 319717

Group type: EXPERIMENTAL
Intervention: Aerosolized delta9-tetrahydrocannabinol (5 to 20 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Aerosolized delta9-tetrahydrocannabinol (5 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Aerosolized delta9-tetrahydrocannabinol
Number of subjects: 16

Group type: COMPARATOR
Intervention: Smoked delta9-tetrahydrocannabinol
Number of subjects: 16
Study: 31997228

Group type: EXPERIMENTAL
Intervention: Shear wave elastography (SWE) in infertile patients (Group A)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (Group B)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: SWE values in group A
Number of subjects: 100
Study: 30917445

Group type: EXPERIMENTAL
Intervention: Methylene Blue Perfusion Test (MBPT)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Air Test (AT)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both tests (MBPT and AT)
Number of subjects: 28
Study: 28783465

Group type: EXPERIMENTAL
Intervention: Laser before bleaching
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Laser after bleaching
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Laser before and after bleaching
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control
Number of subjects: 50
Study: 26243555

Group type: EXPERIMENTAL
Intervention: HeART of Stroke (HoS) plus usual care
Number of subjects: 64

Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 64
Study: 23929644

Group type: EXPERIMENTAL
Intervention: LADS mouthrinse (1.4% potassium oxalate)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Positive control (Sensodyne Original desensitising toothpaste)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Negative control (Crest Cavity Protection Regular toothpaste)
Number of subjects: 0
Study: 21853767

Group type: EXPERIMENTAL
Intervention: Sensory awareness lesson with the dominant hand
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Sensory awareness lesson with the nondominant hand
Number of subjects: 29

Group type: COMPARATOR
Intervention: Sham control group
Number of subjects: 29
Study: 19164402

Group type: EXPERIMENTAL
Intervention: Group exercise held twice weekly for five weeks
Number of subjects: 56

Group type: COMPARATOR
Intervention: Usual care (control group) with no person specifically responsible for exercise training
Number of subjects: 56
Study: 16467067

Group type: EXPERIMENTAL
Intervention: Nebulised bronchodilator (ipratropium 0.5 mg + salbutamol 2.5 mg) with 50% O2
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: O2 (50%) alone
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Nebulised bronchodilator (ipratropium 0.5 mg + salbutamol 2.5 mg) alone
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo with room air (RA)
Number of subjects: 16
Study: 15001900

Group type: EXPERIMENTAL
Intervention: Interventional atrial incision/cryoablation during lateral tunnel Fontan
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard lateral tunnel Fontan (Control)
Number of subjects: 42
Study: 12468808

Group type: EXPERIMENTAL
Intervention: Amitriptyline (titrated from 10 to 75 mg in extended-release form)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 9814471

Group type: EXPERIMENTAL
Intervention: Men aged 21-30 years
Number of subjects: 253

Group type: COMPARATOR
Intervention: Men aged 31-86 years
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Short term study (n=36)
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Long term study (n=35)
Number of subjects: 253
Study: 7698617

Group type: COMPARATOR
Intervention: Omeprazole 20 mg t.i.d. for 2 weeks (group O)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg t.i.d. + Amoxicillin 500 mg q.i.d. for 2 weeks (group O + A)
Number of subjects: 31
Study: 2121948

Group type: EXPERIMENTAL
Intervention: High-frequency jet ventilation
Number of subjects: 42

Group type: COMPARATOR
Intervention: Conventional ventilation
Number of subjects: 42
Study: 23134

Group type: COMPARATOR
Intervention: Oral theophylline, placebo aerosol (TP)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Oral placebo, rimiterol aerosol (PR)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Oral theophylline, rimiterol aerosol (TR)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Oral placebo, placebo aerosol (PP)
Number of subjects: 8
Study: 30865175

Group type: EXPERIMENTAL
Intervention: Posttrial visits after TAPIR trial (24 and 48 weeks later)
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Posttrial adherence measured by tenofovir diphosphate levels
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Predictors of adequate adherence posttrial
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Overall adherence after trial completion
Number of subjects: 395
Study: 30186989

Group type: EXPERIMENTAL
Intervention: Combination therapy with ceftizoxime powder and clotrimazole ointment
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 87
Study: 27579635

Group type: EXPERIMENTAL
Intervention: Budesonide-formoterol
Number of subjects: 11693

Group type: COMPARATOR
Intervention: Budesonide
Number of subjects: 11693
Study: 24342715

Group type: EXPERIMENTAL
Intervention: Five ear acupuncture points (Shen‐men, Spleen, Stomach, Hunger, Endocrine)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Hunger acupuncture point only
Number of subjects: 91

Group type: COMPARATOR
Intervention: Sham control (five ear acupuncture points with needles removed immediately after insertion)
Number of subjects: 91
Study: 21993938

Group type: EXPERIMENTAL
Intervention: Independent-port (IP) SSA setup
Number of subjects: 27

Group type: COMPARATOR
Intervention: AD-SSA setups
Number of subjects: 27
Study: 19681572

Group type: EXPERIMENTAL
Intervention: 6-week restorative care educational program (30 minutes weekly)
Number of subjects: 523

Group type: EXPERIMENTAL
Intervention: 6-week restorative care educational program
Number of subjects: 523

Group type: COMPARATOR
Intervention: Control group (single 30-minute in-service on managing behavioral problems)
Number of subjects: 523
Study: 17147835

Group type: EXPERIMENTAL
Intervention: Behavioural/psycho-educational group training for 8 weeks
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo intervention (Control)
Number of subjects: 72
Study: 15113639

Group type: EXPERIMENTAL
Intervention: Cost-sharing group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non cost-sharing group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cost-sharing group (non-chronic diseases)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non cost-sharing group (non-chronic diseases)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cost-sharing group (essential drugs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cost-sharing group (non-essential drugs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non cost-sharing group (essential drugs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non cost-sharing group (non-essential drugs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall impact of cost-sharing program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prescriptions above the upper bound of the cost-sharing schedule
Number of subjects: 0
Study: 11454438

Group type: EXPERIMENTAL
Intervention: 0-hour food deprivation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 6-hour food deprivation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 24-hour food deprivation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Food-deprived participants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Binge eater group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Restrained eaters
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 0
Study: 9398046

Group type: EXPERIMENTAL
Intervention: Fasting plasma vitamin C levels
Number of subjects: 1400
Study: 7706571

Group type: EXPERIMENTAL
Intervention: AT III concentrates administered at an initial dose of 60 U/kg followed by 10 U/kg every six hours
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no treatment with AT III)
Number of subjects: 36
Study: 3123116

Group type: EXPERIMENTAL
Intervention: Combined glyburide-insulin therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 31343149

Group type: EXPERIMENTAL
Intervention: Variable Resistance Training (VRT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (soccer training alone)
Number of subjects: 20
Study: 29380128

Group type: EXPERIMENTAL
Intervention: Fexapotide triflutate 2.5 mg transrectal injectable (FT)
Number of subjects: 995

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 995
Study: 27272079

Group type: EXPERIMENTAL
Intervention: Clindamycin‐BP 3.75% gel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adapalene 0.3%‐BP 2.5% gel
Number of subjects: 0
Study: 24072443

Group type: EXPERIMENTAL
Intervention: Modified phased RF ablation
Number of subjects: 29

Group type: COMPARATOR
Intervention: Conventional phased RF ablation
Number of subjects: 29

Group type: COMPARATOR
Intervention: Irrigated RF ablation
Number of subjects: 29
Study: 23787293

Group type: EXPERIMENTAL
Intervention: Nicotine-containing cigarettes
Number of subjects: 60

Group type: COMPARATOR
Intervention: Denicotinized cigarettes
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nicotine-containing cigarettes (when told they contained nicotine)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Denicotinized cigarettes (when told they were nicotine-free)
Number of subjects: 60
Study: 20839440

Group type: EXPERIMENTAL
Intervention: TCM-WM treatment group
Number of subjects: 128

Group type: COMPARATOR
Intervention: WM control group (SD-Ag)
Number of subjects: 128
Study: 18031547

Group type: EXPERIMENTAL
Intervention: High trough plasma VPA concentrations (above 100 microg/ml for women, above 130 microg/ml for men)
Number of subjects: 265

Group type: COMPARATOR
Intervention: Low trough plasma VPA concentrations (not explicitly defined in the abstract)
Number of subjects: 265
Study: 16159735

Group type: EXPERIMENTAL
Intervention: Single treatment with PDT using topical methyl aminolevulinate (MAL)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Two treatments of MAL-PDT 1 week apart
Number of subjects: 211
Study: 12939002

Group type: EXPERIMENTAL
Intervention: Immediate full occlusal loading
Number of subjects: 28

Group type: COMPARATOR
Intervention: Delayed loading procedure
Number of subjects: 28

Group type: COMPARATOR
Intervention: Both groups (Immediate and Delayed loading)
Number of subjects: 28
Study: 11286374

Group type: EXPERIMENTAL
Intervention: Medical Resonance Therapy Music (MRT‐Music)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 8673775

Group type: EXPERIMENTAL
Intervention: Sublingual captopril
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1438624

Group type: EXPERIMENTAL
Intervention: dl-fenfluramine (1.0 mg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal control subjects
Number of subjects: 0
Study: 3895409

Group type: EXPERIMENTAL
Intervention: Topical streptokinase‐streptodornase (Varidase) solution
Number of subjects: 28

Group type: COMPARATOR
Intervention: Zinc oxide
Number of subjects: 28
Study: 30145927

Group type: EXPERIMENTAL
Intervention: Percutaneous mitral-valve repair in addition to medical therapy
Number of subjects: 304

Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 304
Study: 26809253

Group type: EXPERIMENTAL
Intervention: Insulin Detemir
Number of subjects: 42

Group type: COMPARATOR
Intervention: Insulin Glargine
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Insulin Detemir (second period)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Insulin Glargine (switched to Insulin Detemir)
Number of subjects: 42
Study: 24684165

Group type: EXPERIMENTAL
Intervention: Triple combination cream with fluocinolone acetonide 0.01%, hydroquinone 4%, and tretinoin 0.05% plus sunscreen pre-treatment for 2 weeks.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sunscreen alone for 2 weeks.
Number of subjects: 50
Study: 24147129

Group type: EXPERIMENTAL
Intervention: Placebo group (sham analgesic cream)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 73
Study: 21393578

Group type: EXPERIMENTAL
Intervention: High glucose conditions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Type 2 diabetes patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Optimization of glycemic control
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diabetic carotid endoarterectomy specimens
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hypoxia
Number of subjects: 0
Study: 18339032

Group type: EXPERIMENTAL
Intervention: Vitamin E and selenium supplementation (Vitamin E: 140 mg alpha‐tocopherol and selenium: 200 microg)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 17015865

Group type: EXPERIMENTAL
Intervention: Depression decision support intervention
Number of subjects: 375

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 375
Study: 14623531

Group type: EXPERIMENTAL
Intervention: Letrozole (aromatase inhibitor) with testosterone
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo with testosterone
Number of subjects: 23

Group type: COMPARATOR
Intervention: Testosterone alone (untreated boys)
Number of subjects: 23
Study: 10873072

Group type: EXPERIMENTAL
Intervention: Anastrozole 1 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Anastrozole 10 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Anastrozole (both doses combined)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 24
Study: 8826962

Group type: EXPERIMENTAL
Intervention: Intensive therapy
Number of subjects: 1441

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 1441